# Clustering Approach 4 : RPPA_CHIERARCHICAL
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0945312364941469	Range of duration = 2.56 to 216.92, nDeath = 19, nCensor = 10
2	AGE	ANOVA	0.341010650257921	Range of values = 31 to 85, Mean = 58.4138, StdDev = 16.2602
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.268899735051191	nTypes = 3 (DISTANT METASTASIS/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 4/2/23
4	GENDER	Chi-square test	0.426081645826723	nTypes = 2 (FEMALE/MALE), nPatients = 10/19
5	LYMPH.NODE.METASTASIS	Chi-square test	0.494158705964598	nTypes = 5 (N0/N1A/N1B/N2B/N3), nPatients = 15/2/4/1/4, nMissing = 3
6	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 29
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.189984575112419	nTypes = 12 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/3/2/3/3/2/1/1/1/3/5/1, nMissing = 3